KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients Read more about KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients
Amgen Commences Registered Exchange Offer for Its Senior Floating Rate Notes Due 2008, 5.85 Percent Senior Notes Due 2017 and 6.375 Percent Senior Notes Due 2037 Read more about Amgen Commences Registered Exchange Offer for Its Senior Floating Rate Notes Due 2008, 5.85 Percent Senior Notes Due 2017 and 6.375 Percent Senior Notes Due 2037
New Study Reports Enbrel(R) (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents Read more about New Study Reports Enbrel(R) (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents
Amgen Announces Webcast of 2007 Fourth Quarter and Full Year Financial Results Read more about Amgen Announces Webcast of 2007 Fourth Quarter and Full Year Financial Results
Breakaway from Cancer Public Service Announcement Spreads Support and Hope Read more about Breakaway from Cancer Public Service Announcement Spreads Support and Hope
Amgen Updates 2007 Adjusted EPS Guidance and Outlines 2008 Expense Outlook at the JP Morgan Healthcare Conference Read more about Amgen Updates 2007 Adjusted EPS Guidance and Outlines 2008 Expense Outlook at the JP Morgan Healthcare Conference
Amgen to Present at the 26th Annual JP Morgan Healthcare Conference Read more about Amgen to Present at the 26th Annual JP Morgan Healthcare Conference
Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy Read more about Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
Pivotal Phase 3 Nplate(TM) Study in Non-Splenectomized Patients Met Primary Endpoints Read more about Pivotal Phase 3 Nplate(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints Read more about Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
